Cancer immunotherapy is a revolutionary approach to treating cancer that harnesses the body's own immune system to recognize, attack, and destroy cancer cells. Unlike traditional treatments like chemotherapy and radiation therapy, which directly target cancer cells, immunotherapy aims to enhance the immune system's natural ability to identify and eliminate cancer cells.
Malignant cells are recognized by immune cells through unique mechanisms. Creative Bioarray has devised immune cell-based killing assays employing T cells, NK cells, macrophages, and more. These assays shed light on how new drug candidates impact the immune response against tumors. They help uncover the effectiveness of immunotherapies, whether by bringing cytotoxic immune cells close to tumor targets or by enhancing tumor cell killing through T cell activation and overcoming tolerance.
Through Creative Bioarray's immune cell assay services, researchers can assess the effectiveness of new drug candidates in modulating the immune system and ultimately curtailing tumor growth using in vitro cell models. These services are customizable to match the unique requirements of each research project.
